Alimera Sciences (ALIM) was surging 76% amid heavy trading after ANI Pharmaceuticals (ANIP) said Monday it agreed to acquire Alimera in a deal valued at around $381 million.
More than 6.48 million shares of Alimera traded intraday versus a daily average of roughly 99,000.
Alnylam Pharmaceuticals (ALNY) said Monday that vutrisiran, an investigational therapy for treating ATTR amyloidosis with cardiomyopathy, met its primary and secondary endpoints in the late-stage study.
Shares surged nearly 36% as intraday trading volume climbed to more than 6.68 million versus the stock's daily average of about 578,000.
Nano Nuclear Energy (NNE) said Monday it has acquired annular linear induction pump, or ALIP, intellectual property for small nuclear reactor cooling and heat transfer from Maidana Research's Carlos Maidana.
Shares jumped more than 33% as intraday trading volume advanced to more than 4.56 million from a daily average of about 1.25 million.
Price: 5.54, Change: +2.39, Percent Change: +75.94
Comments